Ignite Creation Date:
2024-05-05 @ 11:01 PM
Last Modification Date:
2024-10-26 @ 10:27 AM
Study NCT ID:
NCT01235975
Status:
COMPLETED
Last Update Posted:
2018-08-20
First Post:
2010-11-04
Brief Title:
Immunogenicity and Safety Study of GSK Biologicals Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline